Fecal microbiota transplantation is not a magical treatment, but better too early than too late

참고문헌 (10)

1. van Nood E, "Duodenal infusion of donor feces for recurrent Clostridium difficile", N Engl J Med, 368, pp.407~415 (2013)
2. Quraishi MN, "Systematic review with meta-analysis : the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection", Aliment Pharmacol Ther, 46, pp.479~493 (2017)
3. Tae-Geun Gweon, "Recognition and attitudes of Korean physicians toward fecal microbiota transplantation: a survey study", The Korean Journal of Internal Medicine, 38(1), pp.48~55 (2023), 대한내과학회[DOI]
4. Hvas CL, "Fecal microbiota transplantation is superior to fidaxomicin for treatment of recurrent Clostridium difficile infection", Gastroenterology, 156, pp.1324~1332 (2019)
5. Baunwall SMD, "The use of faecal microbiota transplantation(FMT)in Europe : a Europe-wide survey", Lancet Reg Health Eur, 9, pp.100181~ (2021)
6. DeFilipp Z, "Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant", N Engl J Med, 381, pp.2043~2050 (2019)
7. Tae-Geun Gweon, "Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea", Journal of Neurogastroenterology and Motility (JNM), 28(1), pp.28~42 (2022), 대한소화기 기능성질환∙운동학회[DOI]
8. Hanssen NM, "Fecal microbiota transplantation in human metabolic diseases : from a murky past to a bright future?", Cell Metab, 33, pp.1098~1110 (2021)
9. McGovern BH, "SER-109, an investigational microbiome drug to reduce recurrence after Clostridioides difficile infection : lessons learned from a phase 2 trial", Clin Infect Dis, 72, pp.2132~2140 (2021)
10. Wei S, "Gut microbiota differs between treatment outcomes early after fecal microbiota transplantation against recurrent Clostridioides difficile infection", Gut Microbes, 14, pp.2084306~ (2022)

관련 논문AI추천